WestHill Financial Advisors’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.54M	Hold	228,333	–	–	0.68%	17
2025 Q4	$4.33M	Hold	228,333	–	–	0.82%	16
2025 Q3	$2.11M	Hold	228,333	–	–	0.41%	19
2025 Q2	$2.6M	Hold	228,333	–	–	0.55%	19
2025 Q1	$2.71M	Hold	228,333	–	–	0.62%	18
2024 Q4	$4.3M	Sell	228,333 -10,000	-4%	-$229K	0.96%	16
2024 Q3	$5.36M	Sell	238,333 -45,000	-16%	-$1.02M	1.2%	16
2024 Q2	$5.91M	Hold	283,333	–	–	1.43%	15
2024 Q1	$4.16M	Hold	283,333	–	–	1.02%	16
2023 Q4	$2.92M	Hold	283,333	–	–	0.78%	17
2023 Q3	$2.23M	Hold	283,333	–	–	0.65%	18
2023 Q2	$2.83M	Hold	283,333	–	–	0.8%	17
2023 Q1	$2.52M	Hold	283,333	–	–	0.75%	17
2022 Q4	$3.11M	Hold	283,333	–	–	0.99%	16
2022 Q3	$3.69M	Hold	283,333	–	–	1.26%	16
2022 Q2	$3.59M	Hold	283,333	–	–	1.19%	16
2022 Q1	$3.97M	Hold	283,333	–	–	1.14%	16
2021 Q4	$8.2M	Hold	283,333	–	–	2.32%	11
2021 Q3	$8.49M	Buy	+283,333	New	+$8.74M	2.62%	10
2021 Q1	$8.81M	Buy	+283,333	New	+$10.7M	3.13%	9